Latest Regulatory News

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.

Carnarvon Energy reports a robust cash balance of A$187 million amid delays in the Dorado project development following Santos' decision to pause FPSO acquisition. The renewal of Bedout Basin exploration permits offers a pathway to future drilling in 2026.

Bathurst Resources reported a first half EBITDA of $27.5 million, surpassing forecasts despite export disruptions, yet lowered its full-year EBITDA guidance to $45-$55 million due to reduced export volumes and softer coal prices.

Cosmos Exploration has secured an exclusive option to acquire EAU Lithium, partnering with Vulcan Energy to deploy cutting-edge Direct Lithium Extraction technology in Bolivia’s lithium-rich salars. This strategic move positions Cosmos at the forefront of sustainable lithium production in the world’s largest lithium resource base.

Dreadnought Resources has released a robust scoping study for its Star of Mangaroon gold project, targeting initial production of around 20,000 ounces at a high grade of 10 g/t. The study outlines strong financial metrics and sets the stage for potential production in 2025, backed by a processing agreement with Black Cat Syndicate.

Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.

Cooper Metals reports promising exploration progress at its Mt Isa East copper-gold project and high-grade gold assays at the Gooroo project, while maintaining a solid cash reserve of $2.1 million.

Eastern Resources Limited's December 2024 quarterly cash flow report reveals a modest operating cash outflow amid ongoing exploration expenses, supported by a healthy cash reserve expected to sustain operations for over 19 quarters.

Dropsuite Limited has entered a binding Scheme Implementation Deed with NinjaOne for a $420 million all-cash acquisition at $5.90 per share, representing a significant premium to recent trading prices. The deal, supported unanimously by Dropsuite’s board and largest shareholder, awaits shareholder and regulatory approvals.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

Clarity Pharmaceuticals will present compelling data on its 64Cu-SAR-bisPSMA diagnostic agent at two leading oncology conferences, highlighting earlier and more accurate prostate cancer lesion detection than current standards.

OzAurum Resources has made significant strides in its Mulgabbie North Gold Project feasibility study, fully funded by Line Hydrogen Pty Ltd, aiming for a near-term cashflow positive trial operation.